JPMorgan Raises Brookfield Corp. Price Target to $73, Maintains Overweight Rating

JPMorgan raised Brookfield Corp.'s price target to $73 from $70 and maintained an Overweight rating. The firm is focusing on the company's long-term growth despite lighter individual quarter contributions from certain businesses.

JPMorgan has increased its price target for Brookfield Corp. (BN) to $73 from $70, while maintaining an Overweight rating on the shares. This move comes following Brookfield's Q2 report and reflects the investment bank's optimism about the company's long-term growth prospects, despite lighter individual quarter contributions from certain businesses [1].

Brookfield Corp., a leading alternative asset manager, has been delivering impressive financial results. Over the past year, the company has seen a 47% return, and its stock is currently trading at $64.42 with a market capitalization of $98.4 billion [2]. The investment bank views Brookfield as a "best-in-class" alternative asset manager, with a strong position in infrastructure, which could benefit from high interest rates and potential asset privatization post-COVID-19 [2].

JPMorgan highlighted Brookfield's ongoing fundraising period, expecting it to significantly increase fee-earning assets and revenue. The firm noted that anticipation of fundraising has historically driven outperformance in other alternative asset manager stocks, and it expects similar results for Brookfield [2].

Brookfield's insurance business has also been identified as a potential key growth engine. The company has demonstrated substantial progress both organically and through acquisitions [2]. Additionally, Brookfield is planning to focus on an investment-led insurer model, similar to Berkshire Hathaway Inc., using its insurance float to back its growing insurance operations [3].

Brookfield's distributable earnings rose to $1.25 billion, or 80 cents a share, excluding gains on asset sales, during the second quarter of 2025. The firm originated over $4 billion of retail and institutional annuity sales, increasing insurance assets to $135 billion [3]. Brookfield also agreed to buy UK insurer Just Group Plc in a deal valued at £2.4 billion, further expanding its footprint in the UK market [3].

Despite a recent miss in earnings per share (EPS) compared to expectations, analysts remain optimistic about Brookfield's potential for future growth. RBC Capital, for instance, raised its price target for Brookfield Corporation from $81.00 to $83.00, maintaining an Outperform rating [2].

References:
[1] https://finance.yahoo.com/news/brookfield-corp-price-target-raised-111047095.html
[2] https://za.investing.com/news/analyst-ratings/jpmorgan-raises-brookfield-stock-price-target-to-73-on-strong-fundraising-outlook-93CH-3833134
[3] https://www.bloomberg.com/news/articles/2025-08-07/brookfield-marks-next-its-era-as-an-investment-led-insurer